DS
TARA icon

DRW Securities’s Protara Therapeutics TARA Stock Holding History

DRW Securities’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-133,543
Closed -$3.07M – 317
2020
Q1 		$3.07M Buy
+133,543
New +$3.89M 0.11% 52
2018
Q4 		– Sell
-622
Closed -$48K – 87
2018
Q3 		$48K Sell
622
-1,220
-66% -$113K ﹤0.01% 47
2018
Q2 		$181K Buy
1,842
+500
+37% +$46.6K 0.01% 74
2018
Q1 		$134K Buy
1,342
+375
+39% +$34.1K 0.01% 138
2017
Q4 		$74K Buy
+967
New +$77.5K 0.01% 442

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DRW Securities's TARA Position: Q2 2020 in Review

DRW Securities sold out of Protara Therapeutics (TARA) in Q2 2020, closing a stake of 133,543 shares — an estimated $3.07M sold.

DRW Securities first reported a position in TARA in Q4 2017 and held it in 5 quarters. The position peaked at $3.07M in Q1 2020. 33 funds tracked by Wall St. Rank hold TARA as of Q2 2020.

  • DRW Securities reported no remaining Protara Therapeutics position as of Q2 2020 after selling out during the quarter.
  • DRW Securities sold 133,543 Protara Therapeutics shares in Q2 2020, an estimated $3.07M.
  • DRW Securities first reported a position in Protara Therapeutics in Q4 2017 and held it in 5 quarters.
  • DRW Securities's Protara Therapeutics position peaked at $3.07M in Q1 2020.
  • 33 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2020.

Based on DRW Securities's 13F filing for Q2 2020, filed 14 Aug 2020.